ATRC
insider transactionsAtriCure, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-13.0K
0 buy · 13.0K sell
Net value · 365d
-$375.8K
$0 in · $375.8K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
3
0 buy · 13.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director
$86.0K
3.0K sh · $28.65
Own -10%
-
Grant·A
Director
$0
6.1K sh
Own +33%
-
Grant·A
Director
$0
6.1K sh
Own +28%
-
Grant·A
Director
$0
6.1K sh
Own +54%
-
Grant·A
Director
$0
6.1K sh
Own +18%
-
Grant·A
Director
$0
6.1K sh
Own +5%
-
Grant·A
Director
$0
6.1K sh
Own +26%
-
Grant·A
Director
$0
6.1K sh
Own +12%
-
Grant·A
Director
$0
6.1K sh
Own +18%
-
Sell·S
Chief Scientific Officer
$140.7K
5.0K sh · $28.13
Own -5%
-
Sell·S
Chief Scientific Officer
$149.2K
5.0K sh · $29.83
Own -5%
-
Exercise·M
Director
$149.9K
10.0K sh · $14.99
Own New
-
Exercise·M
Director
$149.9K
10.0K sh · $14.99
Own +9%
-
Other·G
Michael H Carrel KEY
President, CEO, & Director
$0
1.0K sh
Own -0%
-
Other·G
Michael H Carrel KEY
President, CEO, & Director
$0
5.0K sh
Own -1%
-
Other·F
Chief Scientific Officer
$487.2K
15.6K sh · $31.26
Own -13%
-
Grant·A
Chief Scientific Officer
$0
15.2K sh
Own +15%
-
Grant·A
Chief Scientific Officer
$0
30.4K sh
Own +42%
-
Other·F
Chief Legal Officer
$490.4K
15.7K sh · $31.26
Own -14%
-
Grant·A
Chief Legal Officer
$0
15.2K sh
Own +16%
-
Grant·A
Chief Legal Officer
$0
28.0K sh
Own +41%
-
Other·F
Angela L Wirick KEY
Chief Financial Officer
$717.9K
23.0K sh · $31.26
Own -10%
-
Grant·A
Angela L Wirick KEY
Chief Financial Officer
$0
23.1K sh
Own +11%
-
Grant·A
Angela L Wirick KEY
Chief Financial Officer
$0
40.0K sh
Own +24%
-
Other·F
Chief Mktg & Strategy Officer
$487.2K
15.6K sh · $31.26
Own -13%
-
Grant·A
Chief Mktg & Strategy Officer
$0
15.2K sh
Own +14%
-
Grant·A
Chief Mktg & Strategy Officer
$0
28.0K sh
Own +36%
-
Other·F
Chief Operating Officer
$717.4K
22.9K sh · $31.26
Own -9%
-
Grant·A
Chief Operating Officer
$0
25.5K sh
Own +11%
-
Grant·A
Chief Operating Officer
$0
42.4K sh
Own +23%
-
Other·F
Chief Technical Officer
$410.4K
13.1K sh · $31.26
Own -8%
-
Grant·A
Chief Technical Officer
$0
15.2K sh
Own +10%
-
Grant·A
Chief Technical Officer
$0
30.4K sh
Own +24%
-
Other·F
Michael H Carrel KEY
President, CEO, & Director
$2.3M
72.8K sh · $31.26
Own -8%
-
Grant·A
Michael H Carrel KEY
President, CEO, & Director
$0
101.3K sh
Own +13%
-
Grant·A
Michael H Carrel KEY
President, CEO, & Director
$0
68.6K sh
Own +10%
-
Grant·A
Chief Operating Officer
$7.0K
257 sh · $27.37
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | Karen Prange | Sell S | 3.0K | $86.0K |
| May 18, 2026 | Shlomo Nachman | Grant A | 6.1K | $0 |
| May 18, 2026 | Deborah H Telman | Grant A | 6.1K | $0 |
| May 18, 2026 | Maggie Yuen | Grant A | 6.1K | $0 |
| May 18, 2026 | Regina E Groves | Grant A | 6.1K | $0 |
| May 18, 2026 | Robert S. White | Grant A | 6.1K | $0 |
| May 18, 2026 | Karen Prange | Grant A | 6.1K | $0 |
| May 18, 2026 | Kristine B Johnson | Grant A | 6.1K | $0 |
| May 18, 2026 | Sven Wehrwein | Grant A | 6.1K | $0 |
| May 15, 2026 | Vinayak Doraiswamy | Sell S | 5.0K | $140.7K |
| Mar 12, 2026 | Vinayak Doraiswamy | Sell S | 5.0K | $149.2K |
| Mar 10, 2026 | Robert S. White | Exercise M | 10.0K | $149.9K |
| Mar 10, 2026 | Robert S. White | Exercise M | 10.0K | $149.9K |
| Mar 6, 2026 | Michael H Carrel KEY | Other G | 1.0K | $0 |
| Mar 6, 2026 | Michael H Carrel KEY | Other G | 5.0K | $0 |
| Mar 1, 2026 | Vinayak Doraiswamy | Other F | 15.6K | $487.2K |
| Mar 1, 2026 | Vinayak Doraiswamy | Grant A | 15.2K | $0 |
| Mar 1, 2026 | Vinayak Doraiswamy | Grant A | 30.4K | $0 |
| Mar 1, 2026 | Karl S. Dahlquist | Other F | 15.7K | $490.4K |
| Mar 1, 2026 | Karl S. Dahlquist | Grant A | 15.2K | $0 |
| Mar 1, 2026 | Karl S. Dahlquist | Grant A | 28.0K | $0 |
| Mar 1, 2026 | Angela L Wirick KEY | Other F | 23.0K | $717.9K |
| Mar 1, 2026 | Angela L Wirick KEY | Grant A | 23.1K | $0 |
| Mar 1, 2026 | Angela L Wirick KEY | Grant A | 40.0K | $0 |
| Mar 1, 2026 | Justin J Noznesky | Other F | 15.6K | $487.2K |
| Mar 1, 2026 | Justin J Noznesky | Grant A | 15.2K | $0 |
| Mar 1, 2026 | Justin J Noznesky | Grant A | 28.0K | $0 |
| Mar 1, 2026 | Douglas J Seith | Other F | 22.9K | $717.4K |
| Mar 1, 2026 | Douglas J Seith | Grant A | 25.5K | $0 |
| Mar 1, 2026 | Douglas J Seith | Grant A | 42.4K | $0 |
| Mar 1, 2026 | Salvatore Privitera | Other F | 13.1K | $410.4K |
| Mar 1, 2026 | Salvatore Privitera | Grant A | 15.2K | $0 |
| Mar 1, 2026 | Salvatore Privitera | Grant A | 30.4K | $0 |
| Mar 1, 2026 | Michael H Carrel KEY | Other F | 72.8K | $2.3M |
| Mar 1, 2026 | Michael H Carrel KEY | Grant A | 101.3K | $0 |
| Mar 1, 2026 | Michael H Carrel KEY | Grant A | 68.6K | $0 |
| Dec 31, 2025 | Douglas J Seith | Grant A | 257 | $7.0K |
About ATRC insider trading
This page tracks insider transactions for AtriCure, Inc. (ATRC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.